How does Sitagliptin improve the safety profile of dual antidiabetic therapies, particularly in reducing hypoglycemia and other side effects when combined with other medications?
Sunil JoshiExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Sitagliptin, by enhancing insulin secretion only when glucose levels are elevated, lowers the risk of hypoglycemia compared to other add-ons.